I believe in one of the Proactive interviews Dr. Pourhassan said he was introduced to the CEO of Amarex by a now former FDA Commissioner in 2012... both Iranian background ...

Kazem Kazempour, PhD - President & CEO Amarex

Here you go... read away:

https://investorshangout.com/post/view?id=5721889


https://twitter.com/AmarexClinical/media

Quote:

---

Amarex Clinical Research, LLC
@AmarexClinical
·
Mar 20
We worked with client CytoDyn to prepare, submit and achieve FDA approval for an EUA for leronlimab as a potential treatment for COVID-19.

We also submitted a rush IND application for leronlimab as a treatment of respiratory illness caused by COVID-19.

---

https://finance.yahoo.com/amphtml/news/amarex...52293.html